Challenge 4: Knowing what to digitalize - and what not to digitalize
Digitalization in the pharmaceutical industry covers a vast expanse of technologies in virtually every part of a CDMO – but innovation a CDMO pursues should always be one that will add value.
While there may be significant potential in Machine Learning, Artificial Intelligence, Blockchain, and Big Data, adopting these technologies purely for the sake of innovation can be a costly mistake.
CDMO Solution: Focus on initiatives that add value
Smart CDMOs focus on initiatives that can increase quality and efficiency. Start by identifying low-hanging fruit — relatively small projects that will generate quick wins. For example, replacing a data-entry book at a visual inspection workstation with a tablet is simple for users to learn, and can add value through efficiency.
While these initiatives are underway, identify projects that may require greater effort but bring far greater value. For example, completely redesigning a formerly paper-based, manual data-transfer system is far more complex.
But having a system that automatically sends data from laboratory measuring equipment to storage and processing software could be well-worth that effort.